143

Neurology
Focuses on brain health.
Sub Categories on Neurology
Latest Articles
DNA vaccine protects against toxic proteins linked to Alzheimer's

DNA vaccine protects against toxic proteins linked to Alzheimer's

by UT Southwestern Medical CenterUT Southwestern researchers have developed a DNA vaccine that helps the body protect against toxic proteins associated with Alzheimer's disease. These images

DNA vaccine protects against toxic proteins linked to Alzheimer's

by UT Southwestern Medical CenterUT Southwestern researchers have developed a DNA vaccine that helps the body protect against toxic proteins associated with Alzheimer's disease. These images
LSL60101 compound reduces neuroinflammation and improves cognition

LSL60101 compound reduces neuroinflammation and improves cognition

by University of BarcelonaCredit: Pixabay/CC0 Public DomainThe LSL60101 compound, a specific ligand of the I2-IR receptors in the brain, could shed light on the development of future strategies a

LSL60101 compound reduces neuroinflammation and improves cognition

by University of BarcelonaCredit: Pixabay/CC0 Public DomainThe LSL60101 compound, a specific ligand of the I2-IR receptors in the brain, could shed light on the development of future strategies a
DNA vaccine reduces both toxic proteins linked to Alzheimer's

DNA vaccine reduces both toxic proteins linked to Alzheimer's

by UT Southwestern Medical CenterToxic amyloid plaques (red) and tau tangles (brown) form on the brain of a mouse modeled to have Alzheimer's disease. A study shows a DNA vaccine reduces both

DNA vaccine reduces both toxic proteins linked to Alzheimer's

by UT Southwestern Medical CenterToxic amyloid plaques (red) and tau tangles (brown) form on the brain of a mouse modeled to have Alzheimer's disease. A study shows a DNA vaccine reduces both
FDA approves much-debated Alzheimer's drug panned by experts

FDA approves much-debated Alzheimer's drug panned by experts

by Matthew PerroneIn this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administratio

FDA approves much-debated Alzheimer's drug panned by experts

by Matthew PerroneIn this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administratio
GSA's KAER toolkit promotes care conversations on brain health, cognitive status

GSA's KAER toolkit promotes care conversations on brain health, cognitive status

by The Gerontological Society of AmericaCredit: Pixabay/CC0 Public DomainThe Gerontological Society of America (GSA) has released a new edition of its KAER toolkit, which is intended to support primar

GSA's KAER toolkit promotes care conversations on brain health, cognitive status

by The Gerontological Society of AmericaCredit: Pixabay/CC0 Public DomainThe Gerontological Society of America (GSA) has released a new edition of its KAER toolkit, which is intended to support primar
Detecting dementia in the blood

Detecting dementia in the blood

by Swiss Federal Laboratories for Materials Science and TechnologyEmpa researcher Peter Nirmalraj analyzes blood samples using atomic force microscopy (AFM). Credit: EmpaIf the suspicion of Alzhe

Detecting dementia in the blood

by Swiss Federal Laboratories for Materials Science and TechnologyEmpa researcher Peter Nirmalraj analyzes blood samples using atomic force microscopy (AFM). Credit: EmpaIf the suspicion of Alzhe
Hope for Alzheimer's blood test

Hope for Alzheimer's blood test

by Macquarie UniversityBoxplots comparing plasma Aβ1-42/Aβ1-40 ratio, p-tau181, GFAP, and NfL between CU Aβ−, CU Aβ+, MCI Aβ−, MCI Aβ+, and AD Aβ+ groups at timepoint 1. Plasma measures were comp

Hope for Alzheimer's blood test

by Macquarie UniversityBoxplots comparing plasma Aβ1-42/Aβ1-40 ratio, p-tau181, GFAP, and NfL between CU Aβ−, CU Aβ+, MCI Aβ−, MCI Aβ+, and AD Aβ+ groups at timepoint 1. Plasma measures were comp
FDA approves drug for rare form of ALS

FDA approves drug for rare form of ALS

by Cara MurezThe U.S. Food and Drug Administration on Tuesdayapproveda new drug for people who have a rare, inherited type of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig&

FDA approves drug for rare form of ALS

by Cara MurezThe U.S. Food and Drug Administration on Tuesdayapproveda new drug for people who have a rare, inherited type of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig&
Maria shriver and AARP take on Alzheimer's in women

Maria shriver and AARP take on Alzheimer's in women

by Serena Gordon, Healthday ReporterMaria Shriver(HealthDay)—An Alzheimer's diagnosis is devastating, no matter your sex. But the disease strikes far more women than men.Journalist and author Mari

Maria shriver and AARP take on Alzheimer's in women

by Serena Gordon, Healthday ReporterMaria Shriver(HealthDay)—An Alzheimer's diagnosis is devastating, no matter your sex. But the disease strikes far more women than men.Journalist and author Mari
Caregiver burden in dementia during the COVID-19 crisis

Caregiver burden in dementia during the COVID-19 crisis

by IOS PressCredit: CC0 Public DomainCaregivers of people with dementia and milder forms of neurocognitive disorder bear a heavy burden. They are constantly confronted with challenging symptoms a

Caregiver burden in dementia during the COVID-19 crisis

by IOS PressCredit: CC0 Public DomainCaregivers of people with dementia and milder forms of neurocognitive disorder bear a heavy burden. They are constantly confronted with challenging symptoms a
FDA panel urges rejection of experimental Alzheimer's drug

FDA panel urges rejection of experimental Alzheimer's drug

by Marilynn Marchione and Matthew PerroneIn this Dec. 12, 2019 photo provided by Biogen, a scientist works on Alzheimer's disease research in a laboratory at the drugmaker's headquarters in Ca

FDA panel urges rejection of experimental Alzheimer's drug

by Marilynn Marchione and Matthew PerroneIn this Dec. 12, 2019 photo provided by Biogen, a scientist works on Alzheimer's disease research in a laboratory at the drugmaker's headquarters in Ca
FDA approves first drug meant to ease Alzheimer's-linked agitation

FDA approves first drug meant to ease Alzheimer's-linked agitation

by Cara MurezA medication to treat agitation in Alzheimer's patients now has approval from the U.S. Food and Drug Administration.The FDA gave supplemental approval to Otsuka Pharmaceutical Company

FDA approves first drug meant to ease Alzheimer's-linked agitation

by Cara MurezA medication to treat agitation in Alzheimer's patients now has approval from the U.S. Food and Drug Administration.The FDA gave supplemental approval to Otsuka Pharmaceutical Company